Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the international lymphoma epidemiology consortium

被引:268
作者
De Sanjose, Silvia [1 ]
Benavente, Yolanda [1 ]
Vajdic, Claire M. [2 ]
Engels, Eric A. [3 ]
Morton, Lindsay M. [3 ]
Bracci, Paige M. [4 ]
Spinelli, John J. [5 ]
Zheng, Tongzhang [6 ]
Zhang, Yawei [6 ]
Franceschi, Silvia [7 ]
Talamini, Renato [8 ]
Holly, Elizabeth A. [4 ]
Grulich, Andrew E. [2 ]
Cerhan, James R. [9 ]
Hartge, Patricia [3 ]
Cozen, Wendy [10 ]
Boffetta, Paolo [7 ]
Brennan, Paul [7 ]
Maynadie, Marc [11 ]
Cocco, Pierluigi [12 ]
Bosch, Ramon [13 ]
Foretova, Lenka [14 ]
Staines, Anthony [15 ]
Becker, Nikolaus [16 ]
Nieters, Alexandra [16 ]
机构
[1] Hosp Llobregat, Ctr Invest Biomed Red Epidemiol & Salud Publ, Inst Invest Biomed Bellvitge, Catalan Inst Oncol,Unit Ingect & Canc, Barcelona 08907, Spain
[2] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
[3] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA
[4] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[5] British Columbia Canc Agcy, Canc Control Res Program, Vancouver, BC V5Z 4E6, Canada
[6] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
[7] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France
[8] Aviano Canc Ctr, Epidemiol & Biostat Unit, I-33081 Aviano, Italy
[9] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA
[10] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[11] Fac Med Dijon, Registre Hemopathies Malignes Cote Or, Dijon, France
[12] Univ Cagliari, Dept Publ Hlth, Occupat Hlth Sect, Cagliari, Italy
[13] Hosp Tortosa Verge de la Cinta, Dept Pathol, Tortosa, Spain
[14] Masaryk Mem Canc Inst, Brno, Czech Republic
[15] Publ Hlth Univ Coll, Dept Publ Hlth, Dublin, Ireland
[16] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany
关键词
D O I
10.1016/j.cgh.2008.02.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: increasing evidence points towards a role of hepatitis C virus (HCV) infection in causing malignant lymphomas. We pooled case-control study data to provide robust estimates of the risk of non-Hodgkin's lymphoma (NHL) subtypes after HCV infection. Methods: The analysis included 7 member studies from the International Lymphoma Epidemiology Consortium (InterLymph) based in Europe, North America, and Australia. Adult cases of NHL (n = 4784) were diagnosed between 1988 and 2004 and controls (n = 6269) were matched by age, sex, and study center. All studies used third-generation enzyme-linked immunosorbent assays to test for antibodies against HCV in serum samples. Participants who were human immunodeficiency virus positive or were organ-transplant recipients were excluded. Results: HCV infection was detected in 172 NHL cases (3.60%) and in 169 (2.70%) controls (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.40 -2.25). In subtype-specific analyses, HCV prevalence was associated with marginal zone lymphoma (OR, 2.47; 95% CI, 1.44-4.23), diffuse large B-cell lymphoma (OR, 2.24; 95% CI, 1.682.99), and lymphoplasmacytic lymphoma (OR, 2.57; 95% CI, 1.14-5.79). Notably, risk estimates were not increased for follicular lymphoma (OR, 1.02; 95% CI, 0.65-1.60). Conclusions: These results confirm the association between HCV infection and NHL and specific B-NHL subtypes (diffuse large B-cell lymphoma, marginal zone lymphoma, and lymphoplasmacytic lymphoma).
引用
收藏
页码:451 / 458
页数:8
相关论文
共 54 条
[1]   BAFF mediates survival of peripheral immature B lymphocytes [J].
Batten, M ;
Groom, J ;
Cachero, TG ;
Qian, F ;
Schneider, P ;
Tschopp, J ;
Browning, JL ;
Mackay, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1453-1465
[2]   TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma [J].
Batten, M ;
Fletcher, C ;
Ng, LG ;
Groom, J ;
Wheway, J ;
Laâbi, Y ;
Xin, XG ;
Schneider, P ;
Tschopp, J ;
Mackay, CR ;
Mackay, F .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :812-822
[3]   Consortia in cancer epidemiology: Lessons from InterLymph [J].
Boffetta, Paolo ;
Armstrong, Bruce ;
Linet, Martha ;
Kasten, Carol ;
Cozen, Wendy ;
Hartge, Patricia .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) :197-199
[4]  
Boffetta Paolo, 2003, Proceedings of the American Association for Cancer Research Annual Meeting, V44, P308
[5]   Hepatitis C infection and lymphomas: Is there any benefit in viral treatment? [J].
Bruni, Laia ;
De Sanjose, Silvia .
GASTROENTEROLOGY, 2006, 131 (02) :685-686
[6]  
Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO
[7]  
2-S
[8]  
Clayton D, 1993, STAT MODELS EPIDEMIO
[9]   Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature [J].
Colin, C ;
Lanoir, D ;
Touzet, S ;
Meyaud-Kraemer, L ;
Bailly, F ;
Trepo, C .
JOURNAL OF VIRAL HEPATITIS, 2001, 8 (02) :87-95
[10]   Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt [J].
Cowgill, KD ;
Loffredo, CA ;
Eissa, SAL ;
Mokhtar, N ;
Abdel-Hamid, M ;
Fahmy, A ;
Strickland, GT .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2004, 33 (05) :1034-1039